Mitapivat (Pyrukynd)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Mitapivat (Pyrukynd), covering 2026-04-21 to 2026-04-21. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Long-term Mitapivat Dosing in Subjects With Stable Sickle Cell Disease: An Extension of a Phase I Pilot Study of Mitapivat [Phase 1, Phase 2]